Author Correction: Utilization of peginterferon-β-1a in the real-world practice for relapsing-remitting multiple sclerosis.

Saved in:
Bibliographic Details
Title: Author Correction: Utilization of peginterferon-β-1a in the real-world practice for relapsing-remitting multiple sclerosis.
Authors: Moccia M; Multiple Sclerosis Unit, Policlinico Federico II University Hospital of Naples, Naples, Italy., Santoni L, Vaccari I, Affinito G, Caliendo D, Rubba F, Lanzillo R, Triassi M, Brescia Morra V, Palladino R
Source: European review for medical and pharmacological sciences [Eur Rev Med Pharmacol Sci] 2024 Feb; Vol. 28 (4), pp. 1241.
Publication Type: Journal Article; Published Erratum
Journal Info: Publisher: Verduci Country of Publication: Italy NLM ID: 9717360 Publication Model: Print Cited Medium: Internet ISSN: 2284-0729 (Electronic) Linking ISSN: 11283602 NLM ISO Abbreviation: Eur Rev Med Pharmacol Sci Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2284-0729
DOI:10.26355/eurrev_202402_35445